SCHEMBL27675488

SCHEMBL27675488

CCOc1ccc(Oc2ccc(S(=O)(=O)N3CCc4ccccc4C3NC(=O)O)cc2Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.44
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MMP2 P08253 2/20 0.41
MMP7 P09237 2/20 0.41
MMP9 P14780 2/20 0.41
MMP12 P39900 2/20 0.41
MMP14 P50281 2/20 0.41
MMP15 P51511 2/20 0.41
MMP16 P51512 2/20 0.41
MMP26 Q9NRE1 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 2/20 0.41
AKR1C3 P42330 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28763110 0.89 MMP1 (0.51) MMP1SMN1; SMN2ALDH1A1NPSR1MMP2
SCHEMBL5165124 0.85 MMP1 (0.47) MMP1NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL5443030 0.84 SMN1; SMN2 (0.44) MMP1NPC1SMN1; SMN2ALDH1A1RAB9A
SCHEMBL27675444 0.81 MMP8 (0.53) MMP1HTTMMP2MMP9MMP12
SCHEMBL27675439 0.78 MMP1 (0.46) MMP1SMN1; SMN2ALDH1A1MMP2MMP7
Carbamic Acid SCHEMBL27675490 0.77 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1RAB9AHPGDHTT
SCHEMBL27693831 0.77 THRB (0.52) MMP1SMN1; SMN2MMP2MMP7MMP9
SCHEMBL5165066 0.75 MMP1 (0.47) MMP1SMN1; SMN2MMP2MMP7MMP9
SCHEMBL5164993 0.75 MMP1 (0.47) MMP1SMN1; SMN2MMP2MMP7MMP9
SCHEMBL5437137 0.74 LMNA (0.44) MMP1NPC1SMN1; SMN2ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed